RSS

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

Sanofi and Regeneron Pharmaceuticals have announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA recommended the approval of the investigational therapy Praluent (alirocumab) injection. more

News